StockNews.com Begins Coverage on Paratek Pharmaceuticals (NASDAQ:PRTK)
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts also recently commented on PRTK. BTIG Research cut their price target on shares of Paratek Pharmaceuticals from $24.00 […]